Skip to main content
. 2024 Jun 18;14:14092. doi: 10.1038/s41598-024-64126-0

Figure 7.

Figure 7

Phenotypic alteration of tumour-infiltrated dendritic cells (DCs) following administration of PAK4 inhibitor in oral squamous cell carcinoma (OSCC) tumour-bearing mice. The phenotypic profiles of DCs in OSCC tumour-bearing mice after administration of the PAK4 inhibitor were analysed. Cells were harvested from the tumours of control or PAK4 inhibitor-treated mice, and the cell-surface expression of various lymphocyte co-stimulatory molecules on CD11c+CD103 and CD11c+CD103+ cells was determined using flow cytometry. Representative histograms are shown (n = 4/group). Numbers in each panel indicate the mean fluorescence intensity of each molecule in control (upper value) and PAK4 inhibitor-treated (lower value) mice.